» Articles » PMID: 31959877

Aneurysmal Subarachnoid Haemorrhage: Effect of CRHR1 Genotype on Mental Health-related Quality of Life

Overview
Journal Sci Rep
Specialty Science
Date 2020 Jan 22
PMID 31959877
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Quality of life (QoL) disturbances are common after aneurysmal subarachnoid hemorrhage (aSAH) both in physical and mental health domains and their causes are not clearly understood. Corticotropin-releasing hormone receptor 1 (CRHR1) is involved in stress reactivity and development of mental health disturbances after negative life-events. We performed a retrospective cohort study of long-term QoL outcomes among 125 surgically treated aSAH patients (2001-2013). QoL was assessed with Short Form Health Survey (SF-36) and compared to an age and gender matched general population. Genotyping of CRHR1 single nucleotide polymorphisms was performed (Rs7209436, Rs110402, Rs242924) and their effect on QoL scores was explored. aSAH patients experienced a reduced quality of life in all domains. CRHR1 minor genotype was associated with higher SF-36 mental health (OR = 1.31-1.6, p < 0.05), role-emotional (OR = 1.57, p = 0.04) and vitality scores (OR = 1.31-1.38, p < 0.05). Association of all studied SNP's with vitality and Rs242924 with mental health scores remained statistically significant after Bonferroni correction. Mental quality of life scores were associated with physical state of patients, antidepressant history and CRHR1 genotype. Predisposition to mental health disturbances after stressful life-events might be associated with reduced mental QoL after aSAH and selected patients could be provided advanced counselling in the recovery phase.

Citing Articles

Diagnosis and management of subarachnoid haemorrhage.

Thilak S, Brown P, Whitehouse T, Gautam N, Lawrence E, Ahmed Z Nat Commun. 2024; 15(1):1850.

PMID: 38424037 PMC: 10904840. DOI: 10.1038/s41467-024-46015-2.


Economic and Humanistic Burden of Cerebral Vasospasm and Its Related Complications after Aneurysmal Subarachnoid Hemorrhage: A Systematic Literature Review.

Thompson J, Chalet F, Manalastas E, Hawkins N, Sarri G, Talbot D Neurol Ther. 2022; 11(2):597-620.

PMID: 35441974 PMC: 9095797. DOI: 10.1007/s40120-022-00348-6.


Aneurysmal subarachnoid haemorrhage: effect of CRHR1 genotype on fatigue and depression.

Vetkas A, Prans E, Koks S, Ratsep T, Asser T BMC Neurol. 2020; 20(1):142.

PMID: 32305063 PMC: 7165373. DOI: 10.1186/s12883-020-01727-y.

References
1.
Rinkel G, Algra A . Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage. Lancet Neurol. 2011; 10(4):349-56. DOI: 10.1016/S1474-4422(11)70017-5. View

2.
Etminan N, Chang H, Hackenberg K, de Rooij N, Vergouwen M, Rinkel G . Worldwide Incidence of Aneurysmal Subarachnoid Hemorrhage According to Region, Time Period, Blood Pressure, and Smoking Prevalence in the Population: A Systematic Review and Meta-analysis. JAMA Neurol. 2019; 76(5):588-597. PMC: 6515606. DOI: 10.1001/jamaneurol.2019.0006. View

3.
Korja M, Lehto H, Juvela S, Kaprio J . Incidence of subarachnoid hemorrhage is decreasing together with decreasing smoking rates. Neurology. 2016; 87(11):1118-23. PMC: 5027805. DOI: 10.1212/WNL.0000000000003091. View

4.
Nieuwkamp D, Setz L, Algra A, Linn F, de Rooij N, Rinkel G . Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol. 2009; 8(7):635-42. DOI: 10.1016/S1474-4422(09)70126-7. View

5.
Noble A, Schenk T . Which variables help explain the poor health-related quality of life after subarachnoid hemorrhage? A meta-analysis. Neurosurgery. 2010; 66(4):772-83. DOI: 10.1227/01.NEU.0000367548.63164.B2. View